Tyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) patients was examined for the
levels of C-reactive protein, biomarker of systemic inflammation
Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) Here we report the results of the pilot project of exosomal miRNA expression
levels in clear cell
Balkhiyarova, Z.,
Luciano, R.,
Kaakinen, M.,
Ulrich, A.,
Shmeliov, A.,
Bianchi, M.,
Chioma, L.,
Dallapiccola, B.,
Prokopenko, I.,
Manco, M. (2022) on
levels of FI in Italian youths (beta = 0.31 ln (pmol/l), 95%CI [0.078, 0.54], P = 0.0085), while
Zhao, S.,
Sufianova, G.,
Shapkin, A.,
Mashkin, A.,
Meshcheryakova, S.,
Han, DY (2022) at the cervical (C3-C5) and lower thoracic (Th9-Th10)
levels.
Results: In all patients, on the 5th day of trial
Tyurin, Anton V.,
Akhiyarova, Karina E.,
Valishin, Damir A.,
Sadretdinova, Lidiya D.,
Khusainova, Leonora N.,
Zagidullin, Naufal S.,
Gantseva, Khalida K.,
Pavlov, Valentin N. (2022) — There was an increase in the
levels of leukocytes (p=0.04) and neutrophils (p=0.002) in patients receiving tocilizumab
of polymorphic variants of inflammation genes with MetS and serum
levels of high-sensitivity C-reactive protein
– the
levels
of the psychological present tense, invariant and variable. At the same time, the
signified